Since SIRT6 deficiency leads to enhanced protein synthesis by virtue of increased activation of mTOR signalling, we tested whether pharmacological inhibition of mTOR signalling can rescue cardiac hypertrophy observed under SIRT6 deficient conditions. The gene discussed is MTOR; the disease is cardiac hypertrophy.